A Study to Evaluate EDP 938 Regimens in Children With RSV
NCT04816721
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus (RSV)
Interventions
DRUG:
EDP-938
DRUG:
Placebo
Sponsor
Enanta Pharmaceuticals, Inc